TRADENAME AstraZeneca Pty Ltd
Product name
TRADENAME
Sponsor
Accepted date
Feb-2026
Active ingredients
baxdrostat
Summary of proposed indication
Baxdrostat is proposed to be used in adults to treat high blood pressure. It is added to other blood pressure medicines when those medicines alone do not lower blood pressure enough.
Application type
A (new medicine)
Publication date
Feb-2026